Invite: Expert Access: Barclays KOL call: Injectable Aesthetics market dynamics and emerging innovations (Reads to GALD, IPN, ABBV)

研报英文原文证据摘录

Invite: Expert Access: Barclays KOL call: Injectable Aesthetics market dynamics and emerging innovations (Reads to GALD, IPN, ABBV)

Meet the Speakers

Michelle Ehrlich, MD, is a Dermatologist and Cosmetic Surgeon in private practice at

Dermatology and Laser Center in Manhattan Beach, CA. She also serves as Director of

Cosmetic Dermatology and Surgery for the Harbor-UCLA residency program and a Clinical

Instructor in Dermatology at UCLA. She is board-certified in dermatology. She is an expert

in the landscape and trajectory of the professional skincare industry. Her areas of expertise

include dermal fillers (Botox, Restylane, Hylaform, Sculptra, and collagen) and other

wrinkle smoothing treatments; anti-aging laser treatments; minimally invasive facelift and

facelift alternatives; liposculpture and liposuction; body contouring; treatment of leg veins;

photorejuvenation and photodynamic therapy; adult acne and acne scar treatments; and

laser hair removal and tattoo removal, among other procedures. An experienced

researcher, she is a published author in scientific journals and textbooks. She is a Diplomat

of the American Board of Dermatology and a Fellow of the American Academy of Cosmetic

Surgery. She completed her advanced fellowship in cosmetic surgery, laser, and cosmetic

dermatology at the La Jolla SpaMD, where she trained with a team of cosmetic

dermatologists, facial plastic surgeons, and general plastic and reconstructive surgeons.

Previously, she completed her training in dermatology and internal medicine at the

Cleveland Clinic Foundation.

Meet the Analysts

James Gordon is a Director and Head of the European

Pharma & Biotech Equity Research team at Barclays.

James joined Barclays in November 2025, having spent

c.20 years covering European Pharma & Biotech at J.P.